No Detection of Episomal or Integrated High-Risk Human Papillomavirus in Nonsmall Cell Lung Carcinomas among Korean Population

다국어 초록 (Multilingual Abstract)

Objectives: High-risk human papillomavirus (hrHPV) is known to be a representative cancer-causing agent in the genital and head and neck regions. Many studies have detected hrHPV DNA in nonsmall cell lung carcinoma. However, hrHPV-etiologic correlation in nonsmall cell lung carcinoma remains unclear. This study is designed to determine the prevalence of episomal or integrated hrHPV DNA in nonsmall cell lung carcinoma among the Korean population. Methods: Surgically resected nonsmall cell lung carcinoma tissues, including 134 cases of squamous cell carcinoma (SqCC) and 99 cases of adenocarcinoma (ADC), were examined. In situ hybridization (ISH) for detecting episomal or integrated hrHPV DNA was performed using the INFORM HPV III Family 16 Probe (B) in the Ventana-validated assay. Anyplex II HPV28 detection kit based on real-time polymerase chain reaction was used for HPV DNA detection and genotyping. Results: All members of the study population were of Korean ethnicity. Episomal or integrated hrHPV DNA ISH analysis result was negative in all 233 cases. One SqCC of 89 samples (42 SqCCs and 47 ADCs) was positive for an hrHPV genotype by Anyplex II HPV28 detection kit. Conclusion: Our finding did not demonstrate hrHPV-etiologic correlation in primary lung SqCC and ADC in the Korean population.

참고문헌 (Reference)

1 Jordan RC, "Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials" 36 (36): 945-954, 2012

2 Doxtader EE, "The relationship between p16expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases" 43 (43): 327-332, 2012

3 Cheng YW, "The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women" 61 (61): 2799-2803, 2001

4 Wang F, "RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues" 14 (14): 22-29, 2012

5 Coissard CJ, "Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases" 18 (18): 1606-1609, 2005

6 Chen YC, "Lung adenocarcinoma and human papillomavirus infection" 101 (101): 1428-1436, 2004

7 de Freitas AC, "Human papillomavirus and lung cancinogenesis: an overview" 142 (142): 2415-2427, 2016

8 Bucchi D, "Human papillomavirus and gastrointestinal cancer: a review" 22 (22): 7415-7430, 2016

9 Schiffman M, "Human papillomavirus and cervical cancer" 370 (370): 890-907, 2007

10 van Boerdonk RAA, "High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis" 8 (8): 711-718, 2013

11 Ragin C, "HPV-associated lung cancers: an international pooled analysis" 35 (35): 1267-1275, 2014

12 Marur S, "HPV-associated head and neck cancer: a virus-related cancer epidemic" 11 (11): 781-789, 2010

13 Bishop JA, "Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method" 36 (36): 1874-1882, 2012

14 Chang SY, "Detection of human papillomavirus in non-small cell carcinoma of the lung" 46 (46): 1592-1597, 2015

15 Syrjanen K, "Detection of human papillomavirus in lung cancer:systematic review and meta-analysis" 32 (32): 3235-3250, 2012

16 Kwon MJ, "Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection" 59 (59): 246-249, 2014

17 Estrade C, "Comparison of Seegene Anyplex II HPV28with the PGMY-CHUV assay for human papillomavirus genotyping" 52 (52): 607-612, 2014

18 Parkin DM, "Chapter 2: the burden of HPV-related cancers" 24 (24): S3/11-S3/25, 2006